Sponsors and Exhibitors
Special Thanks to our Sponsors and Exhibitors
Sponsors
Gold
-
Xcell Therapeutics
Since our inception in 2015, Xcell Therapeutics’ focus has been to create a better future for humanity through the application and use of ethical science. With 10 years of research, we have made a breakthrough and developed CellCor™, a serum-free chemically defined media composed of over 200 known compounds. CellCor™ does not contain any animal or plant-derived components, making it a pure CD media
-
Osstem Implant
Osstem Implant is the first implant company that built and pioneered dental implant when South Korea was newborn in medical equipment industry. With the highest quality and competiveness, we expanded as a company that ranks first in Asia, Pacific region and fourth globally. We are leading the national market with 28 corporation in China, Japan ,USA, Germany and 70 sales network globally.
Exhibition
-
KD R&D Center(3D MATERIALS)
KD R&D Center is an affiliated research institute of KD Finechem established in 1973.
We have many branches abroad including the United States, Europe and China.
We have accumulated know-how in the field of fine chemical manufacturing for almost 50 years.
We started the biomaterial business in 2016.
Biomaterials can be used in the field of 3D bioprinting, drug delivery system and medical devices.
Our final goal is to make artificial tissues and transplant them into patients. -
㈜DOCTOR BIO, Inc
㈜닥터바이오는 2008년에 설립된 회사로 Biological & Chemical & Government enterprise 사업을 기반으로한 단계적인 사업을 추진하고 있으며, 차별화된 ITEM과 가격 경쟁력을 바탕으로 국내 정부 출연 연구기관 및 기업과 교육기관 등에 제품을 공급하고 있습니다. 여러 Global 기업의 공식 대리점과 국내 우수 기업 및 제조사와의 총판 및 대리점으로 업무협약을 맺고 유지하고 있어 효율적 운용을 바탕으로 핵심인력을 양성하여 당 사의 사업 전문성을 강화해 나가고자 합니다.
-
-
-
Bio-Medical Science Co., Ltd.
Bio-Medical Science Co., Ltd. has been conducting research in the fields of life science and basic science since 1988.
We have been constantly striving to contribute to the development of life science research by introducing the latest technologies and products into Korea, and as a life science research partner, we have expanded our scope to basic research equipment manufacturing and development, and are continuing to play a new role. -
CHAYON Laboratories Inc.
Since 1997, CHAYON Laboratories Inc. has been introducing the latest technologies and products for life sciences and other related research areas. With its 25 years of service experience and professional knowledge, CHAYON continues to evolve in the rapidly changing field along with the leading scientists and researchers.
Based on the decades of systematic support by our in-house Technical Sales & Application Scientists, CHAYON is focused on providing unrivaled drug development/discovery services in the Drug Discovery area. In addition, CHAYON is leading the market in various research fields by supplying most up-to-date molecular and cell biology related products, as well as pre-clinical imaging and other automation equipment that incorporate the latest technologies.
Aside from the scientific support and its product portfolio, CHAYON is also known for providing preeminent customer satisfaction in all cases and projects; utilizing its own global standard distribution center for systematic logistics, and field support with internationally trained in-house service engineers.
Finding new possibilities and discovering the future is the value pursued by CHAYON for many years, and we believe that value may only become tangible by the hands of researchers. CHAYON Laboratories will be with researchers to realize our value and their mission.
-
ST1 CO., LTD.
자체 전기방사, 바이오프린팅 기술을 기반으로 하여 ㈜에스티원은 다양한 분야에 적용될 될 수 있는 새로운 기술의 나노 섬유 생체 재료, 스캐폴드를 개발, 생산 하고 있습니다.
2차원 세포배양의 한계를 뛰어 넘는 3차원 세포배양 기술로 ㈜에스티원은 생명과학 발전을 이루고 있습니다.
그 동안 쌓아온 생체적합성 소재 활용 기술을 통해 PCL(Polycaprolactone), 콜라겐 등을 비롯한 여러 생채재료를 활용한 연구를 활발히 하며 연구 영역 확대를 위해 병원, 연구기관, 대학 들과의 공동연구도 활발히 진행하고 있습니다.
-
-
-
-
META BIOMED
(주) 메타바이오메드는 보건의료산업발전을 위해 의료용구 제조업체로 1990년 설립 된 이후 지속적인 연구개발을 통하여 치과용 제품뿐만 아니라 외과용 생분해성 수술용봉합사등 우수한 신제품을 개발하고 생산하여 미국, 유럽 등을 포함한 80여 개국에 수출하고 있습니다.
당사는 창사 이래로 기술을 중시하는 기술 집약형 중소기업으로서 R&D투자에 적극적으로 임한 결과 세계일류상품과 국산 신기술 제품으로 선정된 제품들을 포함해서 국내외적으로 인정받은 우수한 제품들을 생산하고 있습니다.
또한 첨단생명공학 전문회사로 한 단계 더 성장하고자 정형외과용 골수복재에 대한 연구를 차세대신기술과제로서 진행시켜 현재는 품목허가 및 양산단계에 있습니다. 이러한 끊임없는 연구개발 결과로 메타바이오메드는 생명공학분야의 창조적인 기업으로 성장해 나갈 것이며 이를 위해 전 임직원은 새로운 가치창조를 추구하고 있습니다.
앞으로 (주)메타바이오메드 임직원은 인류의 생명과 건강을 책임진다는 목표아래 창조와 도전정신으로 의료산업발전은 물론 사회와 고객에게 만족할 수 있는 기업이 되도록 최선을 다하겠습니다. -
-
Labex Inc.
Labex is one of the fastest growing life science distributing companies in Korea with a focus on on-line sales and support of products that spans from simple pipetting systems to ultra-low temperature freezers and bioreactors, as well as countless reagents and antibodies to satisfy different application needs. With its global standard distribution center next to the Gimpo international airport, direct sales force in Gangnam, and over 500 registered dealer network, Labex promises to deliver the latest and most reliable technology to our customers.
-
Curiosis Inc.
Curiosis Inc, is a company that develops, produces, and supplies laboratory equipment in the field of life science.
We provide solution for improving the efficiency of cell-based research processes and endeavor to become a leading company in the bioindustry.
Based on our core technologies in mechanical engineering, biophysics, and electrical engineering,
we aim to provide high-quality products to our customers as well as contribute towards a better future for humanity. -
TPC mechatronics
TPC메카트로닉스는 1973년 그룹 창업 이후 지속적인 기술개발로 국내 최대의 공기압기기 제조업체로 성장하였습니다.
이후 국가산업 발전의 원동력이 되는 공장자동화의 중요성을 인식하여 수입에만 의존하던 동 제품 다수를
국산화하여 국내외 전 산업에 적용하고 있습니다.
최근엔 국내 IT산업과 스마트 산업의 성장 확대로 해당 산업에 필요한 제품을 개발 확대하고 있으며,
해외 현지법인 설립 등을 통한 해외 시장 확대 및 브랜드 국제화를 꾀하고 있습니다.
최근엔 메카트로닉스 기술(공압/모션/3D프린팅/협동로봇)에
바이오 관련 핵심기술을 응용한 ”바이오-메카트로닉스 전문기업”으로 사업 방향을 정하여
4차 산업혁명의 선도적 기업이 되기 위한 발판을 마련하였습니다. -
-
Dr-Kim
‘닥터킴’은 대표제품인 의료용 헤드램프 ‘DKH-50’을 비롯해 최근 개발한 DKH-60, DKH-50S, DKH-40, DKH-30 등 상하 분산광원을 통한 ‘무영등(無影燈)’ 효과의 램프와 간편하게 장착 가능한 루뻬, 고배율 텔레스코프를 통해 국내외 의사들의 많은 사랑을 받고 있는 헤드램프 브랜드이다.
최근 출시한 세계최초 이중배율 헤드램프 루뻬 DKH-60은 굴절형 텔레스코프(2.5X 또는 4.0X)와 1.5배 DKL-6를 통해 선택적으로 루뻬를 사용할 수 있는 장점이 있다. 굴절형 텔레스코프는 시술자의 목디스크를 예방하는 기능을 갖췄다.
DKH-50, DKH-50S 모델에 장착가능한 ‘D-CAM4S’는 실시간 촬영 및 녹화, 캡쳐가 가능하며, 2K의 화질, EIS기능 등이 탑재되어 있다. 무선 HDMI방식으로 모니터 또는 PC로 연결되어, 실시간 프리젠테이션 및 의료교육 등에 활용하기에 탁월하다. 뷰파인더를 통해 실시간으로 촬영이 잘 되는지 확인이 가능한 장점을 가지고 있다.
닥터킴 헤드램프는 2002년 세계최초로 상하 분산광원 헤드램프를 개발하여 특허를 획득했으며, 2007년 ‘세계 특허청 사무총장상’, 2009년 ‘의료인 대상 아이디어 공모 우수상’, 2010년 ‘발명의 날 특허청장상’, 2016년 미국 ‘Edison awards bronze', 2017 KIMES 식약처장상 등을 수상하였다. 2006년 회사 설립 이후 매년 매출증가를 갱신하며 국내 헤드램프 시장을 석권함은 물론, 세계 50여국으로 수출하며 온 세계 의사들로부터 호평을 받고 있다. -
-
-
-
-
Johnson and Johnson Medical Korea
Johnson & Johnson is the largest and most broadly-based healthcare company in the world. We’re producing life-changing breakthroughs every day and have been for the last 130 years. The combination of new technologies and your expertise enables amazing things to happen. Ethicon, part of the Johnson & Johnson families of companies, we believe amazing things happen when you bring people together with a common purpose. We are committed to help advance surgical care so that more patients live longer, more fulfilling lives. We are driven to develop meaningful solutions, enabling our customers to provide the treatment and positive outcomes patients deserve. For more than 80 years, we have provided healthcare professionals with value-driven, best-to-market solutions.
-
-
Innoregen, Inc
Printing Life to Shape the Future"
Bioinks are materials used to create engineered and artificial biological tissues using a 3D bioprinter, and are made up of a combination of cells, hydrogels, and polypeptides. This ink is considered one of the most advanced tools in tissue engineering and regenerative medicine because, as a material that will become a specific biotissue or organ, it must have certain physical and mechanical properties, bio-functionality, bio-compatibility, etc.
Tissue engineering and regenerative medicine has the ultimate goal of replacing damaged tissues and organs in the human body with new, functional tissues and organs composed of various cells.
Therefore, academia and industry are paying close attention to bioprinting, which may enable them to quickly realize this goal, and accordingly, the field of 'artificial organs,' in which bioprinting plays a major role, is growing rapidly. Explosive growth in the market for “bioinks” biomaterials that be printed with a 3D printer is within reach. We at INNOREGEN are attracting great attention from the entire regenerative medicine industry for successfully developing high-functional bioinks. We are the first company in Korea to work on developing bioinks that combine human-derived collagen/human-derived extracellular matrices with hydrogels. -
Hanmi Pharm.Co.,Ltd.
한미약품은 제약산업의 생명인 R&D 투자에 대한 강력한 의지를 바탕으로 효율적이고 전략적인 연구개발 모델을 도출해내는 일에 한미약품의 미래를 걸 계획입니다. 회사의 모든 역량을 R&D에 집중함으로써 신약 파이프라인을 최대한 확보해 세계 무대에서 통하는 글로벌 신약의 탄생 가능성을 높여 나가겠습니다.
●설립일
1973년 6월 15일(분할일 2010년 7월5일)
●대표이사
우종수, 권세창 (각자 대표이사)
●매출액
1조 2,032억원 (K-IFRS 연결기준)
●R&D 투자
1,615억원(매출대비 13.4%)
●임직원 수
2,142명 (2021.12.31. 기준) -
-
-
BORYUNG
The history of Boryung began in 1957 with the opening of the Boryung Pharmacy in Jongno 5-ga, based on the spirit of the founder Kim Seung-ho, who used to ride his bicycle around the city to get medicines for sick people no matter how hard they were to find.
Boryung, which had been in the pharmaceutical wholesale industry, advanced into the pharmaceutical manufacturing in 1963. Boryung’s attempt to invest in the development of vital medicines for patients, rather than being a mere drug manufacturer, laid the foundation for long-term growth in the pharmaceutical business when the company released "Kanarb," the first ARB antihypertensive in South Korea in March 2011.
The founder’s deep devotion with great sincerity to provide “medicine for the sick” has been expanded since 1957 and passed onto our current mission to become an indispensable to human health.
We kindly ask for your consistent attention to our new challenges and journey under the new name Boryung in 2022.
Thank you
-
-
Global Convention City Daegu
It is my great honor and pleasure to invite you to the 12th World Biomaterials Congress (WBC), which will be held in Daegu, South Korea, May 26-31, 2024. WBC is a world-wide highlighting event to provide with a fascinating opportunity, where the participating experts can gather and share the latest information and knowledge in the diverse areas of biomaterials research. The venue for the event, Daegu, is the third-largest city in Korea, rich in cultural heritage sites and blessed with beautiful nature. We are looking forward to seeing you all in WBC 2024 to celebrate this momentous period of knowledge and discovery in biomaterials science, and also to share an enjoyable and memorable moment in a historic city, Daegu, South Korea.
Ki Dong Park
Chair of Organizing Committee WBC 2024 -
Poster Awards
Web banner
-
(주)제노스
Since its establishment in 2004, GENOSS made an endeavor to become the world’s leading medical device company. The primary mission set forth by GENOSS is focusing on delivering treatment solutions and promoting the well-being of its consumers and patients. GENOSS is trying to prepare for a bigger leap forward into the endless competition of the world biotechnology market through our technical innovation. GENOSS has demonstrated a strong commitment to Research & Development, spending considerable portion on R&D as a percentage of sales. GENOSS has immensely experienced and talented R&D professionals for manufacturing world-beating quality of products. In addition, GENOSS strictly fulfills and complies with the international quality regulations, including KGMP, ISO 13485 and ISO 9001. Furthermore, the CE mark on each product confirms its conformity with all of the legal requirements. GEONSS always concentrates on our customers and patients with the very high levels of innovation and technical expertise, providing a wide range of products categorized as vascular devices , Spinal devices , Dermal filler and Bone & Tissue. GENOSS is desired to build on values of trustworthiness and strong partnerships with customers and business partners.
-
-
바이탈에어코리아
바이탈에어는 프랑스 파리에 본사를 두고 있는 에어리퀴드 그룹의 홈 헬스케어 사업 브랜드로서 전 세계 35개 이상의 국가에서 180만 명 이상의 환자들에게 선진 의료 서비스를 제공하고 있습니다.
바이탈에어코리아(VitalAire Korea)는 에어리퀴드(Air Liquide)의 홈헬스케어 한국법인으로 수면 양압기 서비스뿐만 아니라 가정용 인공호흡기 서비스(국내 1위*), 가정용 산소 발생기 서비스(국내 2위*)를 제공하고 있는 국내 최대의 홈헬스케어 전문 기업입니다. (*건강보험공단 장비 등록 기준) -
Daewon Pharmaceutical
In 1958, Daewon Pharm was established on the basis of founding idea: “the realization of human health.” Although we went through chronological changes, it has been our unchanging role and mission to protect the public health as a company specialized in therapeutic agents.
Daewon Pharm is a capable company that has developed new drugs using excellent technological basis and manufacturing facility. We are devoting ourselves to develop numerous new products to improve the quality of life, and trying our best to become the representative pharmaceutical company of the Republic of Korea.
With the mission statement, “Based on our customer’s belief and trust, be a companion that protects the healthy human life,” Daewon Pharm is ready to make new history in the next 100 years to go beyond a-half-century long reputation of being a therapeutic agent specialist.
-
-
Advertisement
-
-
-
-
스미스앤드네퓨
스미스앤드네퓨는 세계적 다국적 기업으로서 약 160년 동안 욕창, 당뇨, 화상, 수술 창상을 포함한 급성 및 만성 상처 관리제품을 전세계 100개국에 생산, 공급하고 있습니다. 자사는 국내 상처치료의 임상적, 학술적 발전을 위해 꾸준히 상처치료의 최신 지견을 교육하고 소개해온 바 있습니다.
특히 상처치료, 정형외과적 골절, 정형외과적 인공관절 삽입물, 보조기 및 지지대, 내시경, 인체 세포 배양에 의한 인조 피부, 재활기구 및 소비자 헬스케어 등의 제품에 이르기까지 효과적이면서 경제적인 제품을 생산, 공급함으로써 의사와 환자를 만족시키고 있습니다. -
일동제약
일동제약은 대한민국 제약기업으로서, 인류의 건강과 행복에 기여할 수 있는 우수한 의약품의 개발과 공급에 주력해왔습니다. 질병의 치료, 예방은 물론, 보다 건강하고 행복한 삶을 위한 새로운 솔루션의 개발을 통해, 고객과 함께 지속 성장하는 초일류기업을 지향합니다.
일동제약은 만성질환치료제, 항암제, 항생제, 소화기계 및 순환기계 치료제 등 전문의약품과, 유산균제 비오비타, 종합비타민 아로나민 등 대한민국을 대표하는 일반의약품 브랜드를 바탕으로 고객의 신뢰를 받아왔습니다. 대한민국 28호 신약인 B형간염치료제 베시보정을 비롯하여 다수의 신약 파이프라인을 보유하고 있으며, 의약품뿐만 아니라 건강기능식품, 의료기기, 화장품, 음료 등 헬스케어를 위한 다양한 신규사업을 통해 토털헬스케어기업의 비전을 완성해가고 있습니다. -
-
-
Stryker Korea
Stryker is one of the world’s leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and hospital outcomes.
-
-
-
Cplus Biotech Pty Ltd
Cplus Biotech PTY LTD (known as Cplus), is a global innovative biotechnology company located in Australia, Cplus Biotech dedicates in the technologies of human stem cells and stem cell derived exosomes, including research, product development, and manufacturing, to accelerate the commercialisation of regenerative medicine and therapies.
-
-
Solmedix Co., Ltd
Solmedix supports the development of medical devices for advanced treatments and diagnoses. The company offers the MOSAIC platform, a unique service model that provides value to ideas, secures intellectual property rights, and commercializes new medical devices to market. Solmedix was founded in 2015 and is based in Seoul, South Korea.
-
EXHIBIT OVERVIEW
EXHIBIT INFORMATION
- Date & Time : Wednesday - Saturday, Oct. 5-8, 2022 from 10am to 6pm
- Location : Lobby, 3F ICC Jeju, South Korea
- Installation : Tuesday, Oct. 4, 13:00~18:00
- Dismantling : Saturday, Oct. 8, 13:30~18:00
IMPORTANT DATES
- August 31, 2022 : Deadline for Application
- September 8, 2022 : Deadline for Payment and Ad Materials Submission
- September, 2022 : Exhibit Space Assignment (Only for paid companies)
CONTACT INFORMATION
KTERMS Secretariat
- 1414 Seocho world officetel 19 Seoun-ro, Seocho-dong, Seocho-gu, Seoul, Korea
- E-mail : kterms@gmail.com Phone : +82-70-7558-2608 Fax : +82-70-8258-2608
TERMIS-AP 2022 Secretariat
- 6F, Sunghwa B/D, #11-13, Hwarang-ro 8-gil, Suseong-gu, Daegu 42038, Korea
- E-mail : termisap2022@gmail.com Phone : +82-53-740-0424 Fax : +82-53-742-9007